Implicit Bioscience Inc — Form D
Implicit Bioscience Inc of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-20. Industry: Biotechnology.
Offering
- Filed: 2013-12-20
- Form: D
- Accession: 0001594821-13-000001
- Industry: Biotechnology
- Exemptions: 06b
- Minimum investment: $1
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-208405
Issuer
- Name: Implicit Bioscience Inc
- CIK: 0001594821
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 550 17TH AVE, SEATTLE, WA, 98122
- Phone: 2064622261
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Garry Llewellyn Redlich | Director | East Brisbane, C3 |
| Garry Llewellyn Redlich | Executive Officer | East Brisbane, C3 |
| Daniel David Syrdal | Director | Mercer Island, WA |
| James Edward Rottsolk | Director | Seattle, WA |
| James Edward Rottsolk | Executive Officer | Seattle, WA |
| Marion Llewellyn Koster | Executive Officer | QLD, C3 |
| Lee Lawrence Huntsman | Director | Seattle, WA |
| Norman Edward Lemay | Director | Gig Harbor, WA |
Other filings by this issuer (1)
More